Evidence of Clonal Hematopoiesis and Risk of Heart Failure

Area of Science:

• Cardiovascular Medicine
• Hematology
• Genetics

Background:

• Clonal hematopoiesis of indeterminate potential (CHIP) involves persistent clonal expansion of hematopoietic stem cells.
• CHIP is increasingly recognized for its association with cardiovascular disease and adverse outcomes in heart failure.

Purpose of the Study:

• To review emerging studies on the prevalence of CHIP.
• To examine the association between CHIP and cardiovascular and heart disease.

Main Methods:

• Review of genomic studies on CHIP mutations and associated risks.
• Analysis of murine studies investigating specific gene mutations (TET2, DNMT3A, JAK2) in cardiac function.
• Examination of clinical outcomes in heart failure patients with CHIP mutations.

Main Results:

• Genomic studies link CHIP mutations to increased risks of arterial disease, stroke, and mortality.
• Murine models show CHIP mutations can decrease cardiac function and increase inflammasome activation post-insult.
• Driver gene mutations in CHIP are associated with worse clinical outcomes in heart failure, potentially due to proinflammatory selection.

Conclusions:

• CHIP is a significant factor in cardiovascular disease and heart failure prognosis.
• Therapeutic targets for CHIP are emerging from recent clinical studies.
• CHIP may serve as a valuable diagnostic tool for assessing risk in heart failure patients.